−3.5776USD
−41.30 MUSD
9.76 MUSD
262.69 M
About Jaguar Health, Inc.
Sector
CEO
Lisa A. Conte
Headquarters
San Francisco
Website
Employees (FY)
49
Founded
2013
ISIN
US47010C7065
FIGI
BBG005Z20406
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of JAGX is 0.1771 USD — it has increased by 7.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jaguar Health, Inc. stocks are traded under the ticker JAGX.
Jaguar Health, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
JAGX stock is 30.01% volatile and has beta coefficient of −0.27. Check out the list of the most volatile stocks — is Jaguar Health, Inc. there?
JAGX earnings for the last quarter are −0.38 USD whereas the estimation was −1.23 USD which accounts for 69.11% surprise. Estimated earnings for the next quarter are −0.98 USD. See more details about Jaguar Health, Inc. earnings.
Jaguar Health, Inc. revenue for the last quarter amounts to 2.81 M USD despite the estimated figure of 2.46 M USD. In the next quarter revenue is expected to reach 2.61 M USD.
Yes, you can track Jaguar Health, Inc. financials in yearly and quarterly reports right on TradingView.
JAGX stock has risen by 59.98% compared to the previous week, the month change is a 153.00% rise, over the last year Jaguar Health, Inc. has showed a 70.48% decrease.
JAGX net income for the last quarter is −9.17 M USD, while the quarter before that showed −7.78 M USD of net income which accounts for −17.90% change. Track more Jaguar Health, Inc. financial stats to get the full picture.
Today Jaguar Health, Inc. has the market capitalization of 45.55 M, it has increased by 10.81% over the last week.
No, JAGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, JAGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jaguar Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 49.00 employees. See our rating of the largest employees — is Jaguar Health, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jaguar Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jaguar Health, Inc. stock shows the sell signal. See more of Jaguar Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jaguar Health, Inc. EBITDA is −31.53 M USD, and current EBITDA margin is −323.04%. See more stats in Jaguar Health, Inc. financial statements.